These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1247 related articles for article (PubMed ID: 22297116)

  • 1. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.
    Guyot P; Ades AE; Ouwens MJ; Welton NJ
    BMC Med Res Methodol; 2012 Feb; 12():9. PubMed ID: 22297116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating hazard ratios from published Kaplan-Meier survival curves: A methods validation study.
    Saluja R; Cheng S; Delos Santos KA; Chan KKW
    Res Synth Methods; 2019 Sep; 10(3):465-475. PubMed ID: 31134735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-linear optimisation method to extract summary statistics from Kaplan-Meier survival plots using the published P value.
    Irvine AF; Waise S; Green EW; Stuart B
    BMC Med Res Methodol; 2020 Oct; 20(1):269. PubMed ID: 33126853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves.
    Liu N; Zhou Y; Lee JJ
    BMC Med Res Methodol; 2021 Jun; 21(1):111. PubMed ID: 34074267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis.
    Hirooka T; Hamada C; Yoshimura I
    Methods Inf Med; 2009; 48(2):104-12. PubMed ID: 19283306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making.
    Cope S; Jansen JP
    BMC Med Res Methodol; 2013 Dec; 13():147. PubMed ID: 24289277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Method for Reconstructing Individual Patient Data From Kaplan-Meier Survival Curves That Incorporate Marked Censoring Times.
    Rogula B; Lozano-Ortega G; Johnston KM
    MDM Policy Pract; 2022; 7(1):23814683221077643. PubMed ID: 35128059
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined test versus logrank/Cox test in 50 randomised trials.
    Royston P; Choodari-Oskooei B; Parmar MKB; Rogers JK
    Trials; 2019 Mar; 20(1):172. PubMed ID: 30885277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice.
    Jachno K; Heritier S; Wolfe R
    BMC Med Res Methodol; 2019 May; 19(1):103. PubMed ID: 31096924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Statistical Analysis Between "Real" Patients Reported in Kaplan-Meier Curves and "Reconstructed" Patients Estimated Through the IPDfromKM Method: Analysis of Eight Trials Evaluating Catheter Ablation of Ventricular Tachycardia.
    Messori A; Fadda V; Romeo MR; Veneziano S; Trippoli S
    Cureus; 2023 Oct; 15(10):e47891. PubMed ID: 37905162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: A comparison of new and existing tests.
    Debray TPA; Moons KGM; Riley RD
    Res Synth Methods; 2018 Mar; 9(1):41-50. PubMed ID: 28975717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
    Horiguchi M; Hassett MJ; Uno H
    Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SurvdigitizeR: an algorithm for automated survival curve digitization.
    Zhang JZ; Rios JD; Pechlivanoglou T; Yang A; Zhang Q; Deris D; Cromwell I; Pechlivanoglou P
    BMC Med Res Methodol; 2024 Jul; 24(1):147. PubMed ID: 39003440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KMSubtraction: reconstruction of unreported subgroup survival data utilizing published Kaplan-Meier survival curves.
    Zhao JJ; Syn NL; Tan BKJ; Yap DWT; Teo CB; Chan YH; Sundar R
    BMC Med Res Methodol; 2022 Apr; 22(1):93. PubMed ID: 35369867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
    Royston P; Parmar MK
    BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.
    Zhao L; Tian L; Uno H; Solomon SD; Pfeffer MA; Schindler JS; Wei LJ
    Clin Trials; 2012 Oct; 9(5):570-7. PubMed ID: 22914867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.